HSPA5 and prostate carcinoma: Two peptides, PKRGFQD and SNTRVAP, which targeted the cell surface of androgen-independent prostate cancer cells, bind specifically to α-2-macroglobulin and 78 kDa glucose-regulated protein, respectively32.